United States
Germany
Japan
United Kingdom
China
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Products
CNY 3,990.00
2周
CNY 3,990.00
2周
Anti-BRAF mouse monoclonal antibody, clone OTI4A5 (formerly 4A5)
| Applications | ELISA, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1E2 (formerly 1E2)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1D2 (formerly 1D2)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI3C3 (formerly 3C3)
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Anti-BRAF mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (85)
- Bladder cancer (85)
- Chemokine signaling pathway (85)
- Chronic myeloid leukemia (85)
- Colorectal cancer (85)
- Endometrial cancer (85)
- ErbB signaling pathway (85)
- Focal adhesion (85)
- Glioma (85)
- Insulin signaling pathway (85)
- Long-term depression (85)
- Long-term potentiation (85)
- MAPK signaling pathway (85)
- Melanoma (85)
- Natural killer cell mediated cytotoxicity (85)
- Neurotrophin signaling pathway (85)
- Non-small cell lung cancer (85)
- Pancreatic cancer (85)
- Pathways in cancer (85)
- Progesterone-mediated oocyte maturation (85)
- Prostate cancer (85)
- Regulation of actin cytoskeleton (85)
- Renal cell carcinoma (85)
- Thyroid cancer (85)
- Vascular smooth muscle contraction (85)
- mTOR signaling pathway (85)
